Amdocs Limited (NASDAQ:DOX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ratings firms that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $92.3333.
DOX has been the subject of a number of recent research reports. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Bank of America cut their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Finally, Stifel Nicolaus lowered their price target on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, February 4th.
Check Out Our Latest Stock Report on DOX
Institutional Inflows and Outflows
Amdocs Stock Up 1.8%
Amdocs stock opened at $69.71 on Monday. The business’s 50-day simple moving average is $76.40 and its two-hundred day simple moving average is $79.82. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The company has a market cap of $7.53 billion, a PE ratio of 13.48, a PEG ratio of 1.23 and a beta of 0.42. Amdocs has a fifty-two week low of $65.74 and a fifty-two week high of $95.41.
Amdocs (NASDAQ:DOX – Get Free Report) last announced its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.06. The firm had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period last year, the business posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Equities analysts anticipate that Amdocs will post 6.21 EPS for the current year.
Amdocs Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be paid a $0.569 dividend. The ex-dividend date is Tuesday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.3%. Amdocs’s dividend payout ratio (DPR) is currently 40.81%.
Amdocs Company Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Read More
- Five stocks we like better than Amdocs
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
